Multiple System Atrophy clinical trials at UCSD
3 in progress, 1 open to eligible people
Durability of Ampreloxetine for the Treatment of Symptomatic NOH in Participants with Multiple System Atrophy
open to eligible people ages 30 years and up
This is a Phase 3, multi-center, randomized withdrawal study to evaluate the efficacy and durability of ampreloxetine in participants with MSA and symptomatic nOH after 20 weeks of treatment. This study includes 4 periods: Screening, open label, randomized withdrawal, and long-term treatment extension (LTE).
La Jolla, California and other locations
Lu AF82422 in Participants With Multiple System Atrophy
Sorry, in progress, not accepting new patients
To find out the effect of Lu AF82422 on disease progression in participants with multiple system atrophy.
La Jolla, California and other locations
Automated Imaging Differentiation of Parkinsonism
Sorry, in progress, not accepting new patients
The purpose of this study is to test the performance of the AID-P across 21 sites in the Parkinson Study Group. Each site will perform imaging, clinical scales, diagnosis, and will upload the data to the web-based software tool. The clinical diagnosis will be blinded to the diagnostic algorithm and the imaging diagnosis will be compared to the movement disorders trained neurologist diagnosis.
La Jolla, California and other locations
Last updated: